Terms and Conditions

Terms and Conditions

The following are the terms and conditions (“Terms of Use”) on which you may use the InCred Capital’s website, www.incredcapital.com (the “Website”) and by accessing the Website, you agree to be bound by them. The term ‘InCred Capital’ or ‘InCred Entities’ refers to InCred Capital Financial Services Limited, and its subsidiaries and affiliates. The Terms of Use shall apply to all services, programs, information, and products that you may use or otherwise access from time to time through the Website. Please read the Terms of Use carefully. By accessing Website and any pages hereof, you are indicating that you have read, acknowledge and agree to be bound by the Terms of Use. If you do not accept these Terms of Use, then please do not use or access the Website or any pages thereof. Apart from the Terms of Use, you also agree to be bound by other Website policies as may be available on the Website. The content of this Website is the property of InCred Capital Financial Services Limited.

DISCLAIMER

By accessing the Website and/or using any information or material provided on or via this Website you agree to have read and be bound by this Disclaimer.

The information and any material provided on this Website or in any communication containing a link to this Website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject InCred Entities to any registration requirement within such jurisdiction or country. Neither the information, nor any material or opinion contained in the Website constitutes a solicitation or offer by InCred Entities or their respective directors, and employees to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service. This information and any material or opinion provided on the Website is for your private information only. We do not represent that the information and any material provided on the Website is accurate or complete. InCred Entities shall not have any responsibility to maintain the Website, data and services made available on the Website. No part of any information or material may be copied or duplicated in any form by any means, or redistributed. All investments are subject to market risks.

In no event will InCred Entities or their respective directors and employees be liable for any damages including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising out of and in connection with the Website or use thereof or inability to use thereof, or in connection with any failure of performance, error, omission, interruption, defect, delay in operation or transmission, computer virus or system failure.

You acknowledge that you have read and understood the Disclaimer statement and other legal information mentioned on the Website and agree to abide by it.

DISCLAIMER OF WARRANTY AND LIMITATION OF LIABILITY

The information on this site is provided “AS IS”. InCred Entities do not, either expressly or impliedly, warrant the accuracy of the information and materials provided herein for any particular purpose and expressly disclaim any warranties of merchantability or fitness for a particular purpose. InCred Entities will not be responsible or liable for any loss, injury, liability or damage that could result from or arise from your usage of the Website, including but not limited to any errors in or omissions from the Website or its content therein and any third party website or content therein directly or indirectly accessed through links made available on the Website, if any, including but not limited to any errors in or omissions therefrom.

InCred Entities do not guarantee the accuracy, validity, reliability, timeliness or completeness of any information or material made available to you for any particular purpose. Neither InCred Entities, nor any of their respective directors, officers or employees, nor any third party vendor will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or interruption of the Website, or resulting from the act or omission of any other party involved in making the Website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the Website or these materials, whether or not the circumstances giving rise to such cause may have been within the control of InCred or of any vendor providing software or services support. In no event will InCred Entities or any such parties be liable to you for any direct, special, indirect, consequential, incidental damages or any other damages of any kind even if InCred Entities or any other party have been advised of the possibility thereof.

WEBSITE CONTENT

Any and all material and information available through the Website is solely for your own personal use and for information purposes only.

InCred Entities reserve the right, at any time and from time to time, in its own discretion to add, modify, or remove any of the material or information available on the Website. These Terms of Use are not intended to, and will not, transfer or grant any rights in or to the information other than those which are specifically described herein, and all rights not expressly granted herein are reserved by InCred Entities or the third-party providers from whom InCred Capital has obtained the information. InCred Capital does not warrant the completeness, timeliness or accuracy or any material and information available on the Website.

The materials and information on the Website is not intended as an offer or solicitation for the purchase of any stock, any other security, or any financial instrument or product or to provide any investment service or investment advice in any jurisdiction. Investment services are subject to market risks. User accesses, uses, and relies upon such information at his own risk.

InCred Capital may offer an online secured access, whether free or subscription based, to its customers/users as part of additional Website services. InCred Capital may in its sole discretion terminate access to or use of the Website for any reason, including without limitation where it believes that such customer/user has not acted in accordance with the Terms of Use of the Website.

USER RESTRICTIONS

You shall not:

  • publish, transmit, or otherwise reproduce any information available on the Website, in whole or in part, in any format to any third party without the express written consent of InCred Capital; alter, obscure, or remove any copyright, trademark or any other notices that are provided to you in connection with the information;
  • access any part of the Website in an unauthorized manner;
  • engage in any activities related to the Website that are contrary to applicable law, regulation or the terms of any agreements you have with InCred Capital;
  • use or cause to be used any robot, spider or any other automatic software or device or process to monitor or copy our Website or its pages, data or content contained therein without our prior expressed written permission; and
  • alter, decompile or reverse engineer any software component of the Website.
INTELLECTUAL PROPERTY

Unless otherwise stated, copyright and all intellectual property rights in and to all content and material presented on the Website (including but not limited to text, audio, video or graphical images), trademarks and logos appearing on the Website are the property of InCred Capital and/or its affiliates and are protected under applicable Indian Laws. No part of any information or material or software from the Website may be (i) copied, removed, photocopied, or duplicated in any form by any means, or (ii) re-distributed without InCred Capital’s prior written consent. If you download any information or material or software from the Website, you agree that you will not copy it or remove or obscure any copyright or other notices or legends contained in any such information. Any infringement shall be strongly defended and pursued to the fullest extent permitted by law.

LINKS TO THIRD PARTY WEBSITES

This Website may provide links to certain third party websites. InCred Capital is providing such links solely as a convenience to you. Such third party websites that have links on our Website may collect personally identifiable information about you. You are advised to check the data protection policies of these third party websites yourself before using those links/sites.

PRIVACY

Use of this Website may be monitored, tracked and recorded. You acknowledge that InCred Capital may use, disclose or transfer any information that you provide through this Website. For more details, please refer to our Privacy Policy located at our website.

CHANGE IN TERMS AND CONDITIONS

InCred Capital reserves the right, in its sole discretion, without any obligation and without any notice, to change these Terms of Use at any time or to suspend and/or deny access to this Website for scheduled or unscheduled maintenance, upgrades, improvements or corrections. InCred Capital does not undertake any obligation or responsibility to update or amend any information. InCred Capital may discontinue or change any product or service described in or offered on the Website at any time in its discretion. Such changes will become effective and binding after their posting on this section of the Website. You are responsible for regularly reviewing and your continued use of the Website constitutes your agreement to all such changes. By continuing to use our products and services and the Website after any posted revision, the visitor/customer accepts to abide by it.

GOVERNING LAW

The Terms of Use is governed by Indian Laws. Any dispute arising with respect to this Terms of Use shall be subject to exclusive jurisdiction of Court (s) at Mumbai.

CONTACT US

If you have any questions, comments, or concerns about the Terms of Use, please write to us at

Bhupinder Singh

Founder, Director and Group CEO, InCred

Bhupinder Singh founded InCred Group in 2016, with InCred Finance starting in March 2016, InCred Capital-Wholesale Banking starting in September 2018, InCred Wealth starting in December 2019, InCred AMC starting in September 2020, and InCred Money in 2023. Prior to InCred, he worked at Deutsche Bank for 16 years in various capacities, in London and Singapore. Most recently, he co-headed the Corporate Banking and Securities (‘CB&S’) of Deutsche Bank for the Asia Pacific region, based in Singapore. In this capacity, he managed Deutsche Bank’s Fixed Income, Equities and Investment Banking divisions and was a member of the global CB&S executive committee. He was also the Head of Corporate Finance division for Deutsche Bank in the Asia Pacific region managing the bank’s corporate coverage, investment banking, capital markets, advisory and treasury solutions businesses

Vijay Gomatam

Advisor – Industrials

Vijay Gomatam has over 20 years of banking experience across M&A, corporate finance, capital markets, and corporate banking, with a strong focus on cross-border deal origination and execution across India, Southeast Asia, Japan, and Australia. He has deep sector expertise in industrials, IT services, media, and telecom, with extensive experience in India - Southeast Asia and India–Japan transactions. Vijay previously served as Director at MUFG Bank, Singapore, where he led the India - Japan M&A corridor, and earlier worked with Deutsche Bank, Merrill Lynch, Houlihan Lokey, and Edelweiss Alternative Asset Advisors.

His transaction experience includes Motherson Group’s acquisition of TSE-listed Yachiyo Industries, Takahata India’s stake sale to SPRL, Toppan Form’s acquisition of PT RDS in Indonesia, Mitsui’s investment in FKS Food & Agri, CVC’s investment in PT LinkNet, and capital market transactions for Southeast Asian media and telecom clients including SingTel, Axiata, and Bakrie Group.

He holds an MBA from IIM Calcutta and a B.E. (Hons.) from Nanyang Technological University, Singapore.

Akbar Khan

Senior Advisor – Technology

Akbar Khan has over twenty years of experience across M&A advisory, Private Equity, and Corporate M&A, along with a decade as an entrepreneur and operator. He has held senior roles at Bank of America Merrill Lynch in India and London, where he led Telecom & Technology Investment Banking, Private Equity coverage, and M&A, and at General Electric, where he served as Head of Corporate Development and M&A for India and the MENA region. He has advised global corporates and financial sponsors including Reuters Plc, Telecom Italia, Hellenic Telecom, MTN, Tata Group, Apax Partners, Warburg Pincus, and TA Associates, and has led several notable transactions. These include advising E2E Networks on

its USD 50M capital raise, QuEST Global on its USD 75M Series B private placement to Warburg Pincus, Rain Technologies on its USD 65M Series A financing from QED Investors and Invus, Augnito.ai on its Pre-Series A raise from Apollo Hospitals Group, Tata Consultancy Services on the acquisition of Citigroup’s captive back-office unit, Forthnet in Greece on the acquisition of Netmed, and Telecom Italia on the sale of Cosmote via a leveraged buyout by Apax Partners and TPG.

In addition, Akbar co-founded and served as CEO of Rain Technologies India an earned wage access fintech platform.

He holds an MBA from London Business School and is a UK-qualified Chartered Accountant.

Shreyan ML

Managing Director – Healthcare & Pharma

Shreyan ML leads the healthcare and pharma investment banking practice and brings over 15 years of experience across investment banking, corporate M&A, and management consulting within the pharmaceutical sector. Prior to joining MAPE, he worked with Spark Capital, Strides Group, Wanbury Limited, and Tata Strategic Management Group.

His deal experience includes advising Curatio Healthcare on the sale of its business to Torrent Pharmaceuticals; Sale of TTK’s human pharma business to Bharat Serums; Glenmark Pharmaceuticals on the sale of the Razel brand to KKR-backed JB Chemicals & Pharma and the sale of nine dermatology brands to Eris Oaknet.

As Corporate M&A Head at Strides Group, he was involved in thesale of Agila to Mylan and led the animal health strategy at Sequent Scientific, executing over 12 transactions including fundraises and cross-border acquisitions.

He holds an MBA from IIM Indore and is a computer engineer from NIT Karnataka.

Arjun Mukherjee

Managing Director – Industrials

Arjun Mukherjee brings over 20 years of investment banking experience, with a strong focus on mergers & acquisitions and capital raising across Industrials, Education, Telecom, Cement, and Healthcare sectors. Prior to joining InCred Capital, he was part of the senior leadership team at MAPE Advisory Group for over a decade and has previously worked with Lazard, Ambit Capital, and Macquarie Capital.

His deal experience includes advising Veranda Learning on multiple acquisitions and its IPO, Emami on its bid for Paras Pharma, HeidelbergCement on the acquisitions of Mysore Cement and Indo Rama Cement, Italcementi on the acquisition of Sri Vishnu Cement along with an open offer, Bharti Airtel on the acquisitions of Hexacom India and the Spice Calcutta circle, as well as the sale of NLD rights to VSNL, Advent on its bid for Lafarge India.

He has also advised Jagdale Industries on the sale of its electrolyte drinks brand to Johnson & Johnson, promoters of Orissa Sponge on stake sales to Bhushan Steel and Monnet Ispat and on takeover defence, Fortis Healthcare on takeover defence and the sale of a minority stake to Khazanah, ICI India on the sale of its Nitrocellulose business to Actis and its rubber chemicals business, Jai Balaji Industries on the sale of its DI pipe unit and on QIP fund raising, Orbit Corporation and Ansal APIL on QIP-led equity fund raises, Walton Street Capital on raising a USD 500 million India-focused real estate fund, and on acquisition debt funding for the purchase of the RL Fine Chem API business.

Ashish Ambwani

Managing Director – Consumer

Ashish Ambwani has two decades of investment banking experience with a focus on cross-border M&A and Private Equity, and deep sector expertise across Consumption &Retail, Industrials and Digital businesses. He previously served as Director at Lazard for over 12 years and began his career at KPMG.

He has worked on numerous transactions including Osam Dairy’s sale to Dodla Dairy, Livpure’s capital raise from M&G Investments, QIMA’s acquisition of EFRAC Limited, Raymond Consumer Care’s FMCG sale to Godrej Consumer, IPO of Ethos Limited, Manohar Packaging’s sale to Parksons Packaging, MM Polytech’s sale to Huhtamaki, YY Inc.’s acquisition of Bigo, Kama Ayurveda’s fund raise and sale to Puig, Magnet360’s sale to Mindtree, Danone’s acquisition of Wockhardt nutrition assets, UCB’s sale of Indian brands to Dr Reddy’s, Sabero Organics’ sale to Coromandel, International Paper on its acquisition of AP Paper, Avantor on its acquisition of RFCL.

He holds an MBA from IIM Lucknow and a has a degree in Electrical & Electronics Engineering from NIT Trichy.

Jacob Mathew

Managing Director - Investment Banking

Jacob Mathew brings over 25 years of experience in investment banking, private equity, and fundraising. He co-founded MAPE Advisory, a boutique investment bank focused on mid-market companies. Prior to MAPE, he was a Vice President (M&A) at Merrill Lynch India and played a key role in setting up the corporate finance practice at PwC India.

He has worked and led numerous transactions including the acquisition of Coats Viyella’s garment business by the AV Birla Group, the sale of Burnol and Coldarin brands, Dr Reddy’s buyout of American Remedies, and the sale of Diamond Dychem to Ciba AG. At MAPE, he led transactions across technology, telecommunications, consumer, healthcare, and retail sectors. His key clients include Coffee Day Enterprises, Strides, Igarashi Motors, J&J India, and Jyothi Labs.

He holds a PGDM from IIM Calcutta and is a Civil Engineer.

M Ramprasad

Managing Director – Investment Banking

M Ramprasad has over 25 years of experience across investment banking, private equity, and fundraising. He co-founded MAPE Advisory, a boutique Indian investment bank focused on mid-market companies, which later merged with the Investment banking team at InCred in 2020. Prior to MAPE, he was a Senior Vice President at Merrill Lynch India, leading South India operations.

He has led marquee transactions for leading business groups including Tata Group, DuPont, ICICI Bank, Dr Reddy’s, and Sify, and at MAPE advised on landmark deals across manufacturing, infrastructure, and financial services. His key clients include Murugappa Group, ELGi Equipments, Curatio, Jyothi Labs, Karvy Financial Group, Star Health, and CRH Group.

He holds a PGDM from BIM Trichy and a degree in Chemistry.

Sanjay Singh

Head of Investment Banking – InCred Capital

Sanjay Singh is the Head of Investment Banking at InCred Capital, where he leads coverage across both advisory and equity capital markets. He brings over 20 years of experience across investment banking, strategy, and operations, with deep expertise in the pharmaceuticals and healthcare sectors.

Prior to joining InCred, he held leadership roles at BDA Partners as Head of India and Co-Head of Healthcare Asia, and at KPMG as Partner and Head of Life Sciences in India. He has also worked with Dr. Reddy’s Laboratories and Glenmark Pharmaceuticals.

His transaction experience includes advising Chemfield Cellulose on its divestment to Oji Holdings, Archimica S.p.A. on its acquisition by PI Industries, Synokem Pharmaceuticals on growth investment from TA Associates, Isagro SpA on the divestment of Isagro Asia Agrochemicals to PI Industries, SMT on its equity raise from Morgan Stanley Private Equity, Astec LifeSciences on the sale of equity to Godrej Agrovet and Nihon Nohyaku on its acquisition of Hyderabad Chemical Limited amongst others.

Sanjay holds an MBA from IIM Bangalore and a B Tech from IIT BHU.